News

A2 Healthcare is honored to announce that we received the “Best Contract Research Organization” award at the Citeline Japan Awards 2025, held in Tokyo on October 21, 2025.

Celebrating its fourth domestic edition, the Awards bring together hundreds of innovative leaders to network, discover new opportunities, and reflect on breakthrough achievements across the pharmaceutical industry. The program recognizes excellence and innovation in Japan’s pharma and biotech sectors and underscores Japan’s vital role in the global healthcare market.

In the CRO category, judging focused on service quality and the strength of partnerships with sponsor companies.
Our award reflects recognition across the following areas:

• 　・Innovative patient recruitment strategies
• 　・Global market development and new-drug entry support
• 　・High-quality services and continuous talent development
• 　・Strong sponsor and partner satisfaction
• 　・Advancements in data quality, transparency, and operational efficiency
• 　・Clinical trial digital transformation and adoption of new technologies

Committed to alleviating drug lag and drug loss, A2 Healthcare will continue to go beyond the traditional role of a CRO to deliver more innovative treatment opportunities to patients in Japan.